生物制药公司Tharimmune, Inc.宣布两项重要人事任命。公司正式任命马克·温德兰为董事会主席,同时擢升安吉拉·拉德科夫斯基为首席运营官。此次高层调整旨在强化公司治理结构,优化运营效率,为下一阶段的战略发展提供强有力的领导支持。
生物制药公司Tharimmune, Inc.宣布两项重要人事任命。公司正式任命马克·温德兰为董事会主席,同时擢升安吉拉·拉德科夫斯基为首席运营官。此次高层调整旨在强化公司治理结构,优化运营效率,为下一阶段的战略发展提供强有力的领导支持。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.